 | BeiGene, Ltd. | |||
| NMS : BGNE || Location: Cayman Islands | ||||
$149.07+4.95 (+3.43%) |
0.1 M | 146.16 - 149.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.841 M |
| March 28, 2024 | 1.731 M |
| March 15, 2024 | 1.731 M |
| Feb. 29, 2024 | 1.747 M |
| Feb. 15, 2024 | 1.747 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.83 | -1.95 | -135.57% |
| 09/30/2023 | -1.90 | 1.09 | 157.25% |
| 06/30/2023 | -1.82 | -1.96 | -8.03% |
| 03/31/2023 | -1.79 | -1.81 | -1.25% |
| 12/31/2022 | -0.95 | -2.38 | -150.68% |
BGNE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 104.490M | Shares Float | 104.490M |
| Short Float | 1.841M | Market Cap | 15059.10M |
| Institution ownership | 48.12% | Insider ownership | 19.832% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -8.45 | Forward EPS | -4.45 |